Radiation for hematologic malignancies: from cell killing to immune cell priming

Area of Science:

• Cancer Immunology
• Radiotherapy
• Hematological Malignancies

Background:

• Radiotherapy's role is shifting towards immune response stimulation.
• Understanding radiotherapy-immune interplay in hematological cancers is emerging.
• This review focuses on recent advances in immunotherapy and adoptive cell therapy for blood cancers.

Purpose of the Study:

• To review recent advances in immunotherapy and adoptive cell therapy for hematological malignancies.
• To highlight evidence supporting the integration of radiation therapy and immunotherapy.
• To explain how radiation therapy stimulates and enhances anti-tumor immune responses.

Main Methods:

• Review of current literature on radiotherapy, immunotherapy, and hematological malignancies.
• Analysis of evidence for combining radiation therapy with immunotherapies.
• Discussion of radiotherapy's role in facilitating adoptive cell therapy, such as CAR T cells.

Main Results:

• Radiation therapy can be combined with immunotherapy to enhance anti-tumor immunity.
• Radiotherapy acts as a bridge to improve CAR T cell engraftment and activity.
• Combining radiotherapy with immunotherapy may lead to chemo-free treatment regimens.

Conclusions:

• Radiotherapy primes anti-tumor immune responses, augmenting immunotherapy and adoptive cell therapy.
• Novel uses of radiotherapy in hematological malignancies are emerging due to its immunogenic potential.
• Integration of radiotherapy and immunotherapy offers a promising path for treating blood cancers.